Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 36.15
+1.70 (4.93%)
Nov 10, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 1.65 billion as of November 9, 2026. It is the 29,588th most valuable company in the world and the 1,726th biggest in Taiwan. Its market cap has increased by 13.32% in one year.
Market Cap
1.65B
Enterprise Value
2.06B
Revenue
650.87M
Global Rank
Country Rank
#1,726 Taiwan
PE Ratio
23.94
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 1.65B, an increase of 115.48%. That is a compound annual growth rate of 3.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.65B | 16.61% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Allied Biotech | 2.60B |
| TSH Biopharm Corporation | 2.36B |
| Merdury Biopharmaceutical | 2.33B |
| PhytoHealth | 2.11B |
| Johnson Chemical Pharmaceutical Works | 1.77B |
| Anxo Pharmaceutical | 1.19B |
| InnoPharmax | 1.13B |
| GeneFerm Biotechnology | 1.12B |